Revenue, last quarter
$341.3M
+8.9% vs same quarter last year
Net income
$26.3M
+89.4% vs same quarter last year
EPS, diluted
$0.32
+113.3% vs same quarter last year
Operating cash flow
$56.6M
+11.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1.3B | $58.5M |
| FY24 | $1.2B | $54.3M |
| FY23 | $1.1B | $62M |
| FY22 | $786.9M | $30.4M |
| FY21 | $500.6M | $65.8M |
| FY20 | $344.9M | $46.5M |
| FY19 | $229.7M | −$8.6M |
| FY18 | $105.4M | $661K |
| FY17 | $48.6M | −$12.5M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 23.6% | 6.6% | 4.5% |
| FY24 | 21.7% | 5.8% | 4.7% |
| FY23 | 21.9% | 5.7% | 5.7% |
| FY22 | 21.3% | 3% | 3.9% |
| FY21 | 22.4% | 6.5% | 13.1% |
| FY20 | 20.3% | 2.4% | 13.5% |
| FY19 | 19.8% | 4.2% | −3.7% |
| FY18 | 18.4% | −3.3% | 0.6% |
| FY17 | 15.2% | −22.7% | −25.6% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $191.8M |
| FY24 | $173.7M |
| FY23 | $185.2M |
| FY22 | $77.2M |
| FY21 | $23.9M |
| FY20 | $35.2M |
| FY19 | −$4.5M |
| FY18 | $1.7M |
| FY17 | −$10.1M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $81.7M |
| FY24 | $300.3M |
| FY23 | $0 |
| FY22 | $0 |
| FY21 | - |
| FY20 | - |
| FY19 | $185K |
| FY18 | $1.2M |
| FY17 | - |
- Progyny
- Healthcare median
Show the numbers
| Year | Progyny | Healthcare median |
|---|---|---|
| FY25 | 4.5% | −30.6% |
| FY24 | 4.7% | −47% |
| FY23 | 5.7% | −58% |
| FY22 | 3.9% | −80.4% |
| FY21 | 13.1% | −71.9% |
| FY20 | 13.5% | −62.2% |
| FY19 | −3.7% | −46.3% |
| FY18 | 0.6% | −49.6% |
| FY17 | −25.6% | −45.9% |